More about

Weight Loss

News
November 20, 2024
2 min read
Save

GLP-1RAs confer ‘metabolic benefit,’ lower odds for MASLD after liver transplantation

GLP-1RAs confer ‘metabolic benefit,’ lower odds for MASLD after liver transplantation

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated steatotic liver disease after liver transplantation, noted a presenter at The Liver Meeting.

News
November 14, 2024
2 min read
Save

Weight loss with semaglutide reduces pain, improves function in knee osteoarthritis

Weight loss with semaglutide reduces pain, improves function in knee osteoarthritis

Weight loss from weekly semaglutide injections accompanied significant reductions in pain related to knee osteoarthritis, according to data published in The New England Journal of Medicine.

News
November 13, 2024
2 min read
Save

Low-income, minority community redevelopment may reduce obesity disparities

Low-income, minority community redevelopment may reduce obesity disparities

SAN ANTONIO — Redevelopment of low-income minority communities may help to reduce obesity disparities in this patient population, according to findings presented at ObesityWeek.

News
November 12, 2024
2 min read
Save

Income, insurance status contributes to rationing prescription drugs due to cost

Income, insurance status contributes to rationing prescription drugs due to cost

SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.

News
November 11, 2024
3 min read
Save

Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables

Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

News
November 08, 2024
4 min read
Save

Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit

Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

News
November 08, 2024
3 min watch
Save

VIDEO: ‘We are in a new era of the treatment of obesity,’ but inequity concerns persist

VIDEO: ‘We are in a new era of the treatment of obesity,’ but inequity concerns persist

SAN ANTONIO — In this Healio video exclusive from ObesityWeek, Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FTOS, discusses equitable access to obesity care and treatments in the U.S.

News
November 06, 2024
1 min read
Save

GLP-1 medication access limited by care site, payer type, demographics

GLP-1 medication access limited by care site, payer type, demographics

SAN ANTONIO — Access to GLP-1 medications is potentially impacted by care site, payer type and demographics, highlighting gaps in care that disproportionately affect certain patient subgroups, according to a presentation at ObesityWeek.

News
November 06, 2024
3 min read
Save

GLP-1 alternative well-tolerated, could lead to similar rate of weight loss

GLP-1 alternative well-tolerated, could lead to similar rate of weight loss

SAN ANTONIO — Petrelintide, a novel once-weekly amylin analog, was well-tolerated in a cohort of healthy people with overweight or obesity, while conferring up to 8.6% weight loss at 16 weeks, a speaker reported.

News
November 06, 2024
2 min read
Save

Retatrutide linked to improved health-related quality of life plus weight loss

Retatrutide linked to improved health-related quality of life plus weight loss

SAN ANTONIO — In patients with obesity, the novel triple receptor agonist retatrutide was associated with improvement in health-related quality of life vs. placebo, a speaker reported.

View more